Back to search
Healthy (For Part A)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy (For Part A) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Healthy (For Part A) trials you may qualify forA study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Acute upper and lower respiratory infections are a major public health problem and a leading cause of morbidity and mortality worldwide. The purpose of this tri…
The primary objective of the study is to investigate the safety and tolerability of ascending doses of GSK3862995B following single dose in healthy participants…
This is a 3-part, single-ascending dose Phase 1a randomized, double-blind, placebo-controlled study in healthy volunteers (Part A) and multiple-ascending dose P…
The purpose of this trial is to assess the potential for cytochrome P450 (CYP)-mediated drug-drug interactions (DDIs) with OPC-167832. The study is conducted in…
This Phase 1/2A, randomized, double-blind study will evaluate the safety, tolerability, and pharmacokinetics (PK) of HT31-1 (hCitH3-mAb) in healthy adult volunt…